{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-003382","form_type":"8-K","ticker":"AMTX","cik":"0000738214","company_name":"AEMETIS, INC","filed_at":"2026-02-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.622309+00:00","generated_at":"2026-05-16T04:12:53.055988+00:00","sec_items":["1.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Aemetis Biogas extends $114.7M preferred unit redemption to April 30, 2026; credit agreement triggers if missed","bullets":["Redemption deadline moved from Dec 31, 2025 to Apr 30, 2026; price set at $114.7M including a $2M fee.","If not redeemed, ABGL enters a credit agreement with Protair-X and Third Eye Capital: $114.7M principal, due May 1, 2027.","Credit agreement bears interest at 16% or prime+10%, compounded daily; Aemetis and subsidiaries guarantee and pledge assets.","ABGL has paid $38.3M prior; the $17.5M closing fee is due on redemption date or added to principal if credit agreement is used."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-003382","json":"https://secwatch.observer/filing/0001437749-26-003382.json","markdown":"https://secwatch.observer/filing/0001437749-26-003382.md","text":"https://secwatch.observer/filing/0001437749-26-003382.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/738214/000143774926003382/0001437749-26-003382-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/738214/000143774926003382/amtx20260206_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T04:12:53.055988+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9a33579844b4a151b634ad525804153d14098151","claim":"AEMETIS, INC amended Eleventh Waiver and Amendment to Series A Preferred Unit Purchase Agreement with Protair-X Technologies Inc. and Third Eye Capital Corporation, as agent valued at $114.7 million (effective 2025-12-31).","evidence_excerpt":"On February 4, 2026, Aemetis Biogas LLC (\"ABGL\"), a subsidiary of Aemetis, Inc., entered into an agreement, effective as of December 31, 2025, entitled Eleventh Waiver and Amendment to Series A Preferred Unit Purchase Agreement (\"PUPA Eleventh Amendment\"), with Protair-X Technologies Inc. (\"Holder\") and Third Eye Capital Corporation, as agent for the Holder.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/738214/000143774926003382/0001437749-26-003382-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"Protair-X Technologies Inc. and Third Eye Capital Corporation, as agent"},{"label":"Value","value":"$114.7 million"},{"label":"Effective","value":"2025-12-31"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}